栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/07/18 | 2,459 | 2,517 | 2,459 | 2,507 | +76 | +3.1% | 149,400 |
2018/07/17 | 2,409 | 2,446 | 2,381 | 2,431 | +14 | +0.6% | 106,800 |
2018/07/13 | 2,361 | 2,426 | 2,357 | 2,417 | +56 | +2.4% | 111,200 |
2018/07/12 | 2,352 | 2,435 | 2,349 | 2,361 | +43 | +1.9% | 165,100 |
2018/07/11 | 2,270 | 2,326 | 2,256 | 2,318 | +39 | +1.7% | 123,500 |
2018/07/10 | 2,260 | 2,296 | 2,228 | 2,279 | +26 | +1.2% | 138,200 |
2018/07/09 | 2,220 | 2,259 | 2,190 | 2,253 | +51 | +2.3% | 80,100 |
2018/07/06 | 2,201 | 2,212 | 2,151 | 2,202 | +15 | +0.7% | 114,300 |
2018/07/05 | 2,237 | 2,240 | 2,173 | 2,187 | -48 | -2.1% | 148,700 |
2018/07/04 | 2,181 | 2,257 | 2,167 | 2,235 | +36 | +1.6% | 190,700 |
2018/07/03 | 2,252 | 2,259 | 2,186 | 2,199 | -62 | -2.7% | 157,500 |
2018/07/02 | 2,345 | 2,348 | 2,256 | 2,261 | -96 | -4.1% | 107,600 |
2018/06/29 | 2,385 | 2,385 | 2,304 | 2,357 | -11 | -0.5% | 121,600 |
2018/06/28 | 2,425 | 2,431 | 2,334 | 2,368 | -75 | -3.1% | 148,000 |
2018/06/27 | 2,422 | 2,456 | 2,402 | 2,443 | +21 | +0.9% | 101,600 |
2018/06/26 | 2,457 | 2,465 | 2,410 | 2,422 | -58 | -2.3% | 64,100 |
2018/06/25 | 2,557 | 2,560 | 2,469 | 2,480 | -76 | -3% | 87,000 |
2018/06/22 | 2,479 | 2,558 | 2,479 | 2,556 | +65 | +2.6% | 92,400 |
2018/06/21 | 2,410 | 2,505 | 2,404 | 2,491 | +48 | +2% | 97,000 |
2018/06/20 | 2,419 | 2,447 | 2,385 | 2,443 | +34 | +1.4% | 114,100 |
2018/06/19 | 2,471 | 2,491 | 2,408 | 2,409 | -79 | -3.2% | 195,000 |
2018/06/18 | 2,521 | 2,540 | 2,470 | 2,488 | -61 | -2.4% | 126,900 |
2018/06/15 | 2,547 | 2,579 | 2,507 | 2,549 | +17 | +0.7% | 405,100 |
2018/06/14 | 2,574 | 2,590 | 2,507 | 2,532 | -69 | -2.7% | 144,000 |
2018/06/13 | 2,641 | 2,650 | 2,576 | 2,601 | -39 | -1.5% | 125,100 |
2018/06/12 | 2,616 | 2,647 | 2,597 | 2,640 | +51 | +2% | 141,600 |
2018/06/11 | 2,570 | 2,601 | 2,570 | 2,589 | +22 | +0.9% | 110,200 |
2018/06/08 | 2,480 | 2,575 | 2,480 | 2,567 | +73 | +2.9% | 168,100 |
2018/06/07 | 2,476 | 2,499 | 2,470 | 2,494 | +24 | +1% | 83,500 |
2018/06/06 | 2,464 | 2,483 | 2,430 | 2,470 | -12 | -0.5% | 60,900 |
2018/06/05 | 2,475 | 2,494 | 2,464 | 2,482 | +2 | +0.1% | 59,900 |
2018/06/04 | 2,477 | 2,509 | 2,475 | 2,480 | +30 | +1.2% | 88,700 |
2018/06/01 | 2,436 | 2,478 | 2,421 | 2,450 | -11 | -0.4% | 79,000 |
2018/05/31 | 2,409 | 2,497 | 2,396 | 2,461 | +54 | +2.2% | 162,700 |
2018/05/30 | 2,395 | 2,437 | 2,383 | 2,407 | -13 | -0.5% | 84,900 |
2018/05/29 | 2,420 | 2,436 | 2,396 | 2,420 | -1 | ±0% | 73,900 |
2018/05/28 | 2,424 | 2,442 | 2,406 | 2,421 | +2 | +0.1% | 65,300 |
2018/05/25 | 2,420 | 2,447 | 2,405 | 2,419 | -17 | -0.7% | 70,900 |
2018/05/24 | 2,450 | 2,454 | 2,420 | 2,436 | -5 | -0.2% | 69,500 |
2018/05/23 | 2,426 | 2,457 | 2,424 | 2,441 | +5 | +0.2% | 96,500 |
2018/05/22 | 2,447 | 2,465 | 2,416 | 2,436 | +7 | +0.3% | 59,400 |
2018/05/21 | 2,432 | 2,441 | 2,406 | 2,429 | +15 | +0.6% | 103,500 |
2018/05/18 | 2,440 | 2,441 | 2,393 | 2,414 | +8 | +0.3% | 139,600 |
2018/05/17 | 2,389 | 2,407 | 2,353 | 2,406 | +12 | +0.5% | 122,900 |
2018/05/16 | 2,370 | 2,405 | 2,341 | 2,394 | +16 | +0.7% | 120,400 |
2018/05/15 | 2,397 | 2,408 | 2,362 | 2,378 | -46 | -1.9% | 148,600 |
2018/05/14 | 2,360 | 2,430 | 2,360 | 2,424 | +38 | +1.6% | 91,500 |
2018/05/11 | 2,316 | 2,388 | 2,316 | 2,386 | +69 | +3% | 129,600 |
2018/05/10 | 2,291 | 2,318 | 2,257 | 2,317 | +9 | +0.4% | 117,500 |
2018/05/09 | 2,282 | 2,315 | 2,201 | 2,308 | -139 | -5.7% | 300,800 |
1551~
1600
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
あすかHD | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム